Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | FRAGA, Raquel Scherer de | |
dc.contributor.author | VAISBERG, Victor Van | |
dc.contributor.author | MENDES, Luiz Claudio Alfaia | |
dc.contributor.author | CARRILHO, Flair Jose | |
dc.contributor.author | ONO, Suzane Kioko | |
dc.date.accessioned | 2020-06-01T14:52:45Z | |
dc.date.available | 2020-06-01T14:52:45Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Nucleos(t)ide analogues (NAs) are the main drug category used in chronic hepatitis B (CHB) treatment. Despite the fact that NAs have a favourable safety profile, undesired adverse events (AEs) may occur during the treatment of CHB. Given the eminent number of patients currently receiving NAs, even a small risk of any of these toxicities can represent a major medical issue. The main objective of this review was to analyse information available on AEs associated with the use of NAs in published studies. We choose the following MesH terms for this systematic review: chronic hepatitis B, side effects and treatment. All articles published from 1 January 1990 up to 19 February 2018 in MEDLINE of PubMed, EMBASE, the Cochrane Library and LILACS databases were searched. A total of 120 articles were selected for analysis, comprising 6419 patients treated with lamivudine (LAM), 5947 with entecavir (ETV), 3566 with tenofovir disoproxil fumarate (TDF), 3096 with telbivudine (LdT), 1178 with adefovir dipivoxil (ADV) and 876 with tenofovir alafenamide (TAF). The most common AEs in all NAs assessed were abdominal pain/discomfort, nasopharyngitis/upper respiratory tract infections, fatigue, and headache. TAF displays the highest density of AEs per patient treated among NAs (1.14 AE/treated patient). In conclusion, treatment of CHB with NAs is safe, with a low incidence of AEs. Despite the general understanding TAF being safer than TDF, the number of patients treated with TAF still is too small in comparison to other NAs to consolidate an accurate safety profile. PROSPERO Registration No. CRD42018086471 | eng |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | Brazilian Council for Development of Science and Technology (CNPq)National Council for Scientific and Technological Development (CNPq) [PQ 308609/2018-2] | |
dc.identifier.citation | JOURNAL OF GASTROENTEROLOGY, v.55, n.5, p.496-514, 2020 | |
dc.identifier.doi | 10.1007/s00535-020-01680-0 | |
dc.identifier.eissn | 1435-5922 | |
dc.identifier.issn | 0944-1174 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/35962 | |
dc.language.iso | eng | |
dc.publisher | SPRINGER JAPAN KK | eng |
dc.relation.ispartof | Journal of Gastroenterology | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright SPRINGER JAPAN KK | eng |
dc.subject | Chronic hepatitis B | eng |
dc.subject | Nucleotide | eng |
dc.subject | nucleoside analogues | eng |
dc.subject | Adverse events | eng |
dc.subject.other | positive chronic hepatitis | eng |
dc.subject.other | tenofovir disoproxil fumarate | eng |
dc.subject.other | long-term efficacy | eng |
dc.subject.other | pegylated interferon alpha-2a | eng |
dc.subject.other | extended lamivudine treatment | eng |
dc.subject.other | adefovir dipivoxil therapy | eng |
dc.subject.other | surface-antigen carriers | eng |
dc.subject.other | oral antiviral therapy | eng |
dc.subject.other | early viral kinetics | eng |
dc.subject.other | one-year trial | eng |
dc.subject.wos | Gastroenterology & Hepatology | eng |
dc.title | Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review | eng |
dc.type | article | eng |
dc.type.category | review | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 28 | |
hcfmusp.contributor.author-fmusphc | RAQUEL SCHERER DE FRAGA | |
hcfmusp.contributor.author-fmusphc | VICTOR VAN VAISBERG | |
hcfmusp.contributor.author-fmusphc | LUIS CLAUDIO ALFAIA MENDES | |
hcfmusp.contributor.author-fmusphc | FLAIR JOSE CARRILHO | |
hcfmusp.contributor.author-fmusphc | SUZANE KIOKO ONO | |
hcfmusp.description.beginpage | 496 | |
hcfmusp.description.endpage | 514 | |
hcfmusp.description.issue | 5 | |
hcfmusp.description.volume | 55 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 32185517 | |
hcfmusp.origem.scopus | 2-s2.0-85082752919 | |
hcfmusp.origem.wos | WOS:000520633400001 | |
hcfmusp.publisher.city | TOKYO | eng |
hcfmusp.publisher.country | JAPAN | eng |
hcfmusp.relation.reference | Agarwal K, 2015, J HEPATOL, V62, P533, DOI 10.1016/j.jhep.2014.10.035 | eng |
hcfmusp.relation.reference | Ahn J, 2016, ALIMENT PHARM THER, V43, P134, DOI 10.1111/apt.13440 | eng |
hcfmusp.relation.reference | Ahn SS, 2014, CLIN MOL HEPATOL, V20, P261, DOI 10.3350/cmh.2014.20.3.261 | eng |
hcfmusp.relation.reference | Al Ashgar H, 2017, SAUDI J GASTROENTERO, V23, P190, DOI 10.4103/sjg.SJG_541_16 | eng |
hcfmusp.relation.reference | Ali HY, 2003, SAUDI MED J, V24, P996 | eng |
hcfmusp.relation.reference | Alsohaibani F, 2015, SAUDI J GASTROENTERO, V21, P295, DOI 10.4103/1319-3767.164189 | eng |
hcfmusp.relation.reference | An J, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0572-2 | eng |
hcfmusp.relation.reference | Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae | eng |
hcfmusp.relation.reference | Berg T, 2014, J HEPATOL, V60, P715, DOI 10.1016/j.jhep.2013.11.024 | eng |
hcfmusp.relation.reference | Berg T, 2010, GASTROENTEROLOGY, V139, P1207, DOI 10.1053/j.gastro.2010.06.053 | eng |
hcfmusp.relation.reference | Booth A, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-2 | eng |
hcfmusp.relation.reference | Buti M, 2016, LANCET GASTROENTEROL, V1, P90, DOI [10.1016/S2468-1253(16)30107-8, 10.1016/S2468-1253(16)30020-6] | eng |
hcfmusp.relation.reference | Buti M, 2015, DIGEST DIS SCI, V60, P1457, DOI 10.1007/s10620-014-3486-7 | eng |
hcfmusp.relation.reference | Buti M, 2012, EUR J GASTROEN HEPAT, V24, P535, DOI 10.1097/MEG.0b013e3283511287 | eng |
hcfmusp.relation.reference | Chan HLY, 2007, ANN INTERN MED, V147, P745, DOI 10.7326/0003-4819-147-11-200712040-00183 | eng |
hcfmusp.relation.reference | Chan HLY, 2016, LANCET GASTROENTEROL, V1, P185, DOI 10.1016/S2468-1253(16)30024-3 | eng |
hcfmusp.relation.reference | Chan HLY, 2014, GASTROENTEROLOGY, V146, P1240, DOI 10.1053/j.gastro.2014.01.044 | eng |
hcfmusp.relation.reference | Chan HLY, 2005, ANN INTERN MED, V142, P240, DOI 10.7326/0003-4819-142-4-200502150-00006 | eng |
hcfmusp.relation.reference | Chang TT, 2009, J VIRAL HEPATITIS, V16, P784, DOI 10.1111/j.1365-2893.2009.01142.x | eng |
hcfmusp.relation.reference | Chang TT, 2005, GASTROENTEROLOGY, V129, P1198, DOI 10.1053/j.gastro.2005.06.055 | eng |
hcfmusp.relation.reference | Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285 | eng |
hcfmusp.relation.reference | Chien RN, 2014, J GASTROEN HEPATOL, V29, P185, DOI 10.1111/jgh.12416 | eng |
hcfmusp.relation.reference | Da Silva LC, 2001, J GASTROENTEROL, V36, P476, DOI 10.1007/s005350170071 | eng |
hcfmusp.relation.reference | de Man RA, 2001, HEPATOLOGY, V34, P578, DOI 10.1053/jhep.2001.26815 | eng |
hcfmusp.relation.reference | Dienstag JL, 2003, HEPATOLOGY, V37, P748, DOI 10.1053/jhep.2003.50117 | eng |
hcfmusp.relation.reference | DIENSTAG JL, 1995, NEW ENGL J MED, V333, P1657, DOI 10.1056/NEJM199512213332501 | eng |
hcfmusp.relation.reference | Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702 | eng |
hcfmusp.relation.reference | Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013 | eng |
hcfmusp.relation.reference | Du Jeong In, 2017, Dig Dis Sci, V62, P2908, DOI 10.1007/s10620-017-4737-1 | eng |
hcfmusp.relation.reference | Du QW, 2013, MED SCI MONITOR, V19, P751, DOI 10.12659/MSM.889443 | eng |
hcfmusp.relation.reference | European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021 | eng |
hcfmusp.relation.reference | Fontana RJ, 2009, HEPATOLOGY, V49, pS185, DOI 10.1002/hep.22885 | eng |
hcfmusp.relation.reference | Fung J, 2011, J ANTIMICROB CHEMOTH, V66, P2715, DOI 10.1093/jac/dkr388 | eng |
hcfmusp.relation.reference | Fung S, 2017, J HEPATOL, V66, P11, DOI 10.1016/j.jhep.2016.08.008 | eng |
hcfmusp.relation.reference | Fung S, 2014, GASTROENTEROLOGY, V146, P980, DOI 10.1053/j.gastro.2013.12.028 | eng |
hcfmusp.relation.reference | Gane EJ, 2011, LIVER INT, V31, P676, DOI 10.1111/j.1478-3231.2011.02490.x | eng |
hcfmusp.relation.reference | Gill US, 2015, J INFECT DIS, V211, P374, DOI 10.1093/infdis/jiu471 | eng |
hcfmusp.relation.reference | Gilson RJC, 1999, J VIRAL HEPATITIS, V6, P387, DOI 10.1046/j.1365-2893.1999.00182.x | eng |
hcfmusp.relation.reference | Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025 | eng |
hcfmusp.relation.reference | Gotham D, 2017, CURR OPIN HIV AIDS, V12, P324, DOI 10.1097/COH.0000000000000379 | eng |
hcfmusp.relation.reference | Guo XH, 2018, INT J ANTIMICROB AG, V52, P201, DOI 10.1016/j.ijantimicag.2018.04.002 | eng |
hcfmusp.relation.reference | Gwak GY, 2013, HEPATOL INT, V7, P106, DOI 10.1007/s12072-012-9368-1 | eng |
hcfmusp.relation.reference | Hadziyannis SJ, 2000, HEPATOLOGY, V32, P847, DOI 10.1053/jhep.2000.17915 | eng |
hcfmusp.relation.reference | Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020 | eng |
hcfmusp.relation.reference | Heo J, 2012, ANTIVIR THER, V17, P1563, DOI 10.3851/IMP2277 | eng |
hcfmusp.relation.reference | Hill A, 2018, J VIRUS ERAD, V4, P72 | eng |
hcfmusp.relation.reference | Hongthanakorn C, 2011, HEPATOLOGY, V53, P1854, DOI 10.1002/hep.24318 | eng |
hcfmusp.relation.reference | Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180 | eng |
hcfmusp.relation.reference | Hou JL, 2015, J VIRAL HEPATITIS, V22, P85, DOI 10.1111/jvh.12313 | eng |
hcfmusp.relation.reference | Hou JL, 2013, J VIRAL HEPATITIS, V20, P811, DOI 10.1111/jvh.12115 | eng |
hcfmusp.relation.reference | Hou JL, 2015, ADV THER, V32, P727, DOI 10.1007/s12325-015-0232-2 | eng |
hcfmusp.relation.reference | Hou JL, 2008, HEPATOLOGY, V47, P447, DOI 10.1002/hep.22075 | eng |
hcfmusp.relation.reference | Huang MX, 2016, CLIN DRUG INVEST, V36, P471, DOI 10.1007/s40261-016-0392-0 | eng |
hcfmusp.relation.reference | Huang MX, 2015, INT J CLIN EXP MED, V8, P666 | eng |
hcfmusp.relation.reference | Imaz A, 2017, EXPERT REV ANTI-INFE, V15, P195, DOI 10.1080/14787210.2017.1286736 | eng |
hcfmusp.relation.reference | Jia HY, 2015, ANN HEPATOL, V14, P175, DOI 10.1016/S1665-2681(19)30779-3 | eng |
hcfmusp.relation.reference | Jia JD, 2014, HEPATOL INT, V8, P72, DOI 10.1007/s12072-013-9488-2 | eng |
hcfmusp.relation.reference | Kamezaki H, 2011, SCAND J GASTROENTERO, V46, P1111, DOI 10.3109/00365521.2011.584898 | eng |
hcfmusp.relation.reference | Karino Y, 2010, HEPATOL INT, V4, P414, DOI 10.1007/s12072-009-9162-x | eng |
hcfmusp.relation.reference | Kayaaslan B, 2017, WORLD J HEPATOL, V9, P227, DOI 10.4254/wjh.v9.i5.227 | eng |
hcfmusp.relation.reference | Kim HR, 2015, LIVER INT, V35, P860, DOI 10.1111/liv.12605 | eng |
hcfmusp.relation.reference | Kim HJ, 2010, J GASTROEN HEPATOL, V25, P1374, DOI 10.1111/j.1440-1746.2010.06381.x | eng |
hcfmusp.relation.reference | Kim HJ, 2010, LIVER INT, V30, P834, DOI 10.1111/j.1478-3231.2010.02245.x | eng |
hcfmusp.relation.reference | Kim HJ, 2015, KOREAN J INTERN MED, V30, P32, DOI 10.3904/kjim.2015.30.1.32 | eng |
hcfmusp.relation.reference | Kobashi H, 2009, J GASTROEN HEPATOL, V24, P255, DOI 10.1111/j.1440-1746.2008.05593.x | eng |
hcfmusp.relation.reference | Koike K, 2018, HEPATOL RES, V48, P59, DOI 10.1111/hepr.12902 | eng |
hcfmusp.relation.reference | Kwon YJ, 2015, NIGER J CLIN PRACT, V18, P796, DOI 10.4103/1119-3077.163296 | eng |
hcfmusp.relation.reference | Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422 | eng |
hcfmusp.relation.reference | Lai CL, 2014, GUT, V63, P996, DOI 10.1136/gutjnl-2013-305138 | eng |
hcfmusp.relation.reference | Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201 | eng |
hcfmusp.relation.reference | Lai CL, 2002, GASTROENTEROLOGY, V123, P1831, DOI 10.1053/gast.2002.37058 | eng |
hcfmusp.relation.reference | Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287 | eng |
hcfmusp.relation.reference | Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI [10.1053/j.gastro.2005.05.053, 10.1016/j.gastro.2005.05.053] | eng |
hcfmusp.relation.reference | Lai CL, 2002, J MED VIROL, V67, P334, DOI 10.1002/jmv.10075 | eng |
hcfmusp.relation.reference | Lai CL, 1997, HEPATOLOGY, V25, P241, DOI 10.1002/hep.510250144 | eng |
hcfmusp.relation.reference | Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470 | eng |
hcfmusp.relation.reference | Lee KS, 2017, CLIN MOL HEPATOL, V23, P331, DOI 10.3350/cmh.2016.0040 | eng |
hcfmusp.relation.reference | Leung NWY, 2014, INFECT DIS THER, V3, P191, DOI 10.1007/s40121-014-0039-5 | eng |
hcfmusp.relation.reference | Leung NWY, 2001, HEPATOLOGY, V33, P1527, DOI 10.1053/jhep.2001.25084 | eng |
hcfmusp.relation.reference | Li XJ, 2013, CLIN THER, V35, P1546, DOI 10.1016/j.clinthera.2013.07.431 | eng |
hcfmusp.relation.reference | Li Y, 2013, J VIRAL HEPATITIS, V20, P46, DOI 10.1111/jvh.12063 | eng |
hcfmusp.relation.reference | Lian JS, 2013, WORLD J GASTROENTERO, V19, P6278, DOI 10.3748/wjg.v19.i37.6278 | eng |
hcfmusp.relation.reference | Liaw YF, 2000, GASTROENTEROLOGY, V119, P172, DOI 10.1053/gast.2000.8559 | eng |
hcfmusp.relation.reference | Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364 | eng |
hcfmusp.relation.reference | Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026 | eng |
hcfmusp.relation.reference | Lim SG, 2007, ALIMENT PHARM THERAP, V26, P1419, DOI 10.1111/j.1365-2036.2007.03506.x | eng |
hcfmusp.relation.reference | Lim YS, 2016, GUT, V65, P1042, DOI 10.1136/gutjnl-2014-308435 | eng |
hcfmusp.relation.reference | Lo AOS, 2014, EXPERT REV GASTROENT, V8, P607, DOI 10.1586/17474124.2014.909724 | eng |
hcfmusp.relation.reference | Lok AS, 2012, GASTROENTEROLOGY, V143, P619, DOI 10.1053/j.gastro.2012.05.037 | eng |
hcfmusp.relation.reference | Lok ASF, 2016, HEPATOLOGY, V63, P284, DOI 10.1002/hep.28280 | eng |
hcfmusp.relation.reference | Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190 | eng |
hcfmusp.relation.reference | Lu DTY, 2000, HEPATOLOGY, V32, P828, DOI 10.1053/jhep.2000.17912 | eng |
hcfmusp.relation.reference | Lu JJ, 2013, J VIRAL HEPATITIS, V20, P40, DOI 10.1111/jvh.12062 | eng |
hcfmusp.relation.reference | Luo J, 2013, INT J MED SCI, V10, P427, DOI 10.7150/ijms.5472 | eng |
hcfmusp.relation.reference | Luo XD, 2017, J VIRAL HEPATITIS, V24, P36, DOI 10.1111/jvh.12790 | eng |
hcfmusp.relation.reference | Mak LY, 2016, EXPERT OPIN DRUG SAF, V15, P383, DOI 10.1517/14740338.2016.1139573 | eng |
hcfmusp.relation.reference | Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431 | eng |
hcfmusp.relation.reference | Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681 | eng |
hcfmusp.relation.reference | Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878 | eng |
hcfmusp.relation.reference | Marcellin P, 2008, HEPATOLOGY, V48, P750, DOI 10.1002/hep.22414 | eng |
hcfmusp.relation.reference | Marcellin P, 2016, DIGEST DIS SCI, V61, P3072, DOI 10.1007/s10620-015-4027-8 | eng |
hcfmusp.relation.reference | Marcellin P, 2016, GASTROENTEROLOGY, V150, P134, DOI 10.1053/j.gastro.2015.09.043 | eng |
hcfmusp.relation.reference | Marcellin P, 2015, J HEPATOL, V62, P41, DOI 10.1016/j.jhep.2014.08.021 | eng |
hcfmusp.relation.reference | Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1 | eng |
hcfmusp.relation.reference | MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743 | eng |
hcfmusp.relation.reference | Mascolo A, 2017, PHARMACOL RES, V123, P122, DOI 10.1016/j.phrs.2017.07.005 | eng |
hcfmusp.relation.reference | Mazur Wlodzimierz, 2002, Med Sci Monit, V8, pCR257 | eng |
hcfmusp.relation.reference | Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007 | eng |
hcfmusp.relation.reference | Montazeri G, 2001, IRAN J MED SCI, V26, P1 | eng |
hcfmusp.relation.reference | Nevens F, 1997, GASTROENTEROLOGY, V113, P1258, DOI 10.1053/gast.1997.v113.pm9322520 | eng |
hcfmusp.relation.reference | Ozaras R, 2014, EUR J GASTROEN HEPAT, V26, P774, DOI 10.1097/MEG.0000000000000099 | eng |
hcfmusp.relation.reference | Pan CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089789 | eng |
hcfmusp.relation.reference | Patterson SJ, 2011, GUT, V60, P247, DOI 10.1136/gut.2010.223206 | eng |
hcfmusp.relation.reference | Perrillo RP, 2011, HEPATOL INT, V5, P654, DOI 10.1007/s12072-010-9228-9 | eng |
hcfmusp.relation.reference | Pol S, 2012, J VIRAL HEPATITIS, V19, P377, DOI 10.1111/j.1365-2893.2012.01602.x | eng |
hcfmusp.relation.reference | Rapti I, 2007, HEPATOLOGY, V45, P307, DOI 10.1002/hep.21534 | eng |
hcfmusp.relation.reference | Ray AS, 2016, ANTIVIR RES, V125, P63, DOI 10.1016/j.antiviral.2015.11.009 | eng |
hcfmusp.relation.reference | Ren FY, 2007, WORLD J GASTROENTERO, V13, P4264, DOI 10.3748/wjg.v13.i31.4264 | eng |
hcfmusp.relation.reference | Ridruejo E, 2014, WORLD J GASTROENTERO, V20, P7169, DOI 10.3748/wjg.v20.i23.7169 | eng |
hcfmusp.relation.reference | Rizzetto M, 2005, J HEPATOL, V42, P173, DOI 10.1016/j.jhep.2004.10.006 | eng |
hcfmusp.relation.reference | Rodriguez M, 2017, WORLD J GASTROENTERO, V23, P7459, DOI 10.3748/wjg.v23.i41.7459 | eng |
hcfmusp.relation.reference | Ruane PJ, 2013, JAIDS-J ACQ IMM DEF, V63, P449, DOI 10.1097/QAI.0b013e3182965d45 | eng |
hcfmusp.relation.reference | Safadi R, 2011, LIVER INT, V31, P667, DOI 10.1111/j.1478-3231.2010.02360.x | eng |
hcfmusp.relation.reference | Santantonio T, 2000, J HEPATOL, V32, P300, DOI 10.1016/S0168-8278(00)80076-8 | eng |
hcfmusp.relation.reference | Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4 | eng |
hcfmusp.relation.reference | Sarin SK, 2005, AM J GASTROENTEROL, V100, P2463, DOI 10.1111/j.1572-0241.2005.00247.x | eng |
hcfmusp.relation.reference | Schiff ER, 2003, J HEPATOL, V38, P818, DOI 10.1016/S0168-8278(03)00076-X | eng |
hcfmusp.relation.reference | Shen HJ, 2016, CELL PHYSIOL BIOCHEM, V40, P370, DOI 10.1159/000452552 | eng |
hcfmusp.relation.reference | Sherman M, 2006, GASTROENTEROLOGY, V130, P2039, DOI 10.1053/j.gastro.2006.04.007 | eng |
hcfmusp.relation.reference | Shin SR, 2011, HEPATOL INT, V5, P664, DOI 10.1007/s12072-010-9238-7 | eng |
hcfmusp.relation.reference | Shindo M, 2009, HEPATOL INT, V3, P445, DOI 10.1007/s12072-009-9135-0 | eng |
hcfmusp.relation.reference | Suh DJ, 2010, ANTIMICROB AGENTS CH, V54, P1242, DOI 10.1128/AAC.01163-09 | eng |
hcfmusp.relation.reference | Sun J, 2014, HEPATOLOGY, V59, P1283, DOI 10.1002/hep.26885 | eng |
hcfmusp.relation.reference | Sung JJY, 2008, J HEPATOL, V48, P728, DOI 10.1016/j.jhep.2007.12.026 | eng |
hcfmusp.relation.reference | Suzuki F, 2008, J GASTROEN HEPATOL, V23, P1320, DOI 10.1111/j.1440-1746.2008.05455.x | eng |
hcfmusp.relation.reference | Tada T, 2018, J GASTROENTEROL, V53, P1196, DOI 10.1007/s00535-018-1467-x | eng |
hcfmusp.relation.reference | Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321 | eng |
hcfmusp.relation.reference | Terrault Norah A, 2018, Clin Liver Dis (Hoboken), V12, P33, DOI 10.1002/cld.728 | eng |
hcfmusp.relation.reference | Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156 | eng |
hcfmusp.relation.reference | Vitoria M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20504 | eng |
hcfmusp.relation.reference | Wang JC, 2013, EUR REV MED PHARMACO, V17, P1162 | eng |
hcfmusp.relation.reference | Wang LC, 2011, HEPATOL INT, V5, P671, DOI 10.1007/s12072-010-9243-x | eng |
hcfmusp.relation.reference | Wang Z, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-388 | eng |
hcfmusp.relation.reference | Wolters LMM, 2001, EUR J GASTROEN HEPAT, V13, P1499, DOI 10.1097/00042737-200112000-00016 | eng |
hcfmusp.relation.reference | Wu IT, 2017, CLIN MICROBIOL INFEC, V23, P464, DOI 10.1016/j.cmi.2017.02.001 | eng |
hcfmusp.relation.reference | Yang FQ, 2017, WORLD J GASTROENTERO, V23, P306, DOI 10.3748/wjg.v23.i2.306 | eng |
hcfmusp.relation.reference | Yao FY, 2000, J HEPATOL, V33, P301, DOI 10.1016/S0168-8278(00)80371-2 | eng |
hcfmusp.relation.reference | Yao GB, 2009, J DIG DIS, V10, P131, DOI 10.1111/j.1751-2980.2009.00375.x | eng |
hcfmusp.relation.reference | Yao Guang-Bi, 2004, Hepatobiliary Pancreat Dis Int, V3, P188 | eng |
hcfmusp.relation.reference | Yokosuka O, 2010, J HEPATOL, V52, P791, DOI 10.1016/j.jhep.2009.12.036 | eng |
hcfmusp.relation.reference | Yuen MF, 2015, J HEPATOL, V62, P526, DOI 10.1016/j.jhep.2014.10.026 | eng |
hcfmusp.relation.reference | Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x | eng |
hcfmusp.relation.reference | Zhang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.024 | eng |
hcfmusp.relation.reference | Zheng MH, 2010, CLIN THER, V32, P649, DOI 10.1016/j.clinthera.2010.04.001 | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | 44ddf22c-aaef-427a-a5fa-6bcb83324de8 | |
relation.isAuthorOfPublication | 38c7e06a-8a9e-4a49-a9da-13a377789a3d | |
relation.isAuthorOfPublication | f07c7e74-63e7-4ada-a6a7-90537211c263 | |
relation.isAuthorOfPublication | 9221b8d6-ad80-46e5-a56f-fb3b28a8c155 | |
relation.isAuthorOfPublication | f49d7b43-1452-4a2a-b4d0-cd8ee887852f | |
relation.isAuthorOfPublication.latestForDiscovery | 44ddf22c-aaef-427a-a5fa-6bcb83324de8 |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_FRAGA_Adverse_events_of_nucleostide_analogues_for_chronic_hepatitis_2020.PDF
- Tamanho:
- 579.1 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)